Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
7th grade Avg
|
New words:
advance, agency, ASC, Asia, assay, ASU, book, called, career, cautioned, certificate, certification, Chad, Codification, companion, deflation, deliverable, delivery, division, driven, embarking, employment, enrichment, entitled, expressly, FIFO, filled, fine, freestanding, Genzyme, grown, highest, honored, hospital, hybridization, immunohistochemistry, imposition, inadequate, increasingly, inInternal, involuntarily, involuntary, kit, launched, ledger, makeup, margin, Marine, menu, merged, moving, necessarily, noncash, NuroPro, obligation, obsolescence, older, people, pharmocogenomic, physician, proficiency, quality, reagent, recruit, reform, refundable, regulatory, reliance, revise, revocation, salary, stand, steel, suggested, suspension, syringe, talent, tangible, team, throughput, top, undergo, undue, update, updated, variety, Ventana, virtually
Removed:
accelerate, Accelerating, acceleration, acid, active, adjustment, allocated, approach, arriving, avoid, award, chemical, choose, collectively, connection, consideration, Cruachem, decision, discounted, evaluated, expressed, external, face, FIN, Glasgow, guidance, hired, identify, implementation, implied, initially, largest, liquidate, making, marketed, November, overhead, participant, prepare, production, remained, repaid, replace, Scotland, structure, unchanged, underlying, undiscounted, voted, Western
Filing tables
Filing exhibits
Related press release
PRPO similar filings
Filing view
External links
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement No. 333-41714, No. 333-69334, No. 333-71866, and No. 333-139999 on Form S-8 of Transgenomic, Inc. and subsidiary, of our report dated February 24, 2010 relating to our audits of the consolidated financial statements appearing in the Annual Report on Form 10-K of Transgenomic Inc. for the years ended December 31, 2009 and December 31, 2008.
/s/ McGladrey & Pullen, LLP
Omaha, Nebraska
February 24, 2010